*** Wednesday, February 3, 2021 at 1pm EST | 12pm CST | 10am PST*** Industry leading ERP & MRP Solutions for Pharma. Join our informative Webinar with AdaptaLogix, the fastest growing NetSuite & Oracle partner, to learn more about the solutions that have been developed to meet mid-market pharma’s unmet needs. ***On demand available after final airing until Feb. 3, 2022***
Register free: https://www.pharmexec.com/pe_w/optimized
Event Overview:
Many mid-market, clinical stage pharmaceutical and biotech companies make do with a patchwork of entry-level solutions to run their business. But as they grow, those disconnected applications often result in manual work and inconsistent data that can cost time and money. In many cases, small accounting teams mistakenly thought they were too small to need a world-class ERP solution. The reality is that clinical stage pharma cannot afford not to invest in ERP.
This webcast features a discussion with Lauren Piunti of Nabriva Therapeutics plc and Chris Degnan of Galera Therapeutics. Lauren and Chris both serve as key people in the decision-making process, implementation and day-to-day operations of ERP systems at their respective firms.
Topics will include who needs ERP, what implementing a new system can provide for a growing pharmaceutical company, when to start your evaluation process, and how to get started.
3 Key Take-aways:
Speakers: James Neal, Managing Partner, AdaptaLogix, LLC
Chris Degnan, CFO, Galera Therapeutics
Lauren Piunti, Associate Director, Finance and Operations, Nabriva Therapeutics plc
Sponsors: Adaptalogix
Oracle Netsuite
Time and Date: Wednesday, February 3, 2021 at 1pm EST | 12pm CST | 10am PST
On demand available after final airing until Feb. 3, 2022
Register free: https://www.pharmexec.com/pe_w/optimized
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.